Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy

Casey J. Lumpkin(Gettysburg College), Matthew E.R. Butchbach(University of Delaware)

Scientific Reports

June 26, 2023

10.1038/s41598-023-37496-0

Cited by 9

Related Papers

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

|Human Molecular Genetics|2009|119

Transcriptome Profiling of Spinal Muscular Atrophy Motor Neurons Derived from Mouse Embryonic Stem Cells

|PLoS ONE|2014|44

Broad proteomics analysis of seeding-induced aggregation of α-synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson’s disease pathogenesis

|Molecular Brain|2024|4

Broad proteomics analysis using in vitro models of Parkinson's disease shows molecular signatures associated with disease progression and identifies potential disease modulators

|Unknown|2023|0